What Women Get Wrong About Alzheimer's Risk: Estrogen, Ovaries and the Brain
Dr. Amy Killen argues that women's longevity is its own field, and that the ovaries act as the pacemakers of aging for the entire body. When estrogen falls, mitochondria, collagen, bone, blood vessels and immune regulation all shift at once. The conversation covers the different forms of estrogen, the reassessed breast cancer data, and why the timing of any hormone conversation appears to matter most for the brain.
Overview
Louisa Nicola sits down with Dr. Amy Killen, chief medical officer of Humanaut Health, for a conversation built entirely around female longevity. Killen's central claim is that the ovaries are the pacemakers of aging: when ovarian function declines, the cardiovascular system, metabolism, brain, bones, muscles and joints all begin to age faster. She explains what actually happens to the egg reserve each month, why inflammation and fibrosis create a hostile microenvironment that accelerates the loss, and which exposures (phthalates, smoking) appear to speed ovarian aging.
The pair then walk through estrogen itself: what it is, where it comes from, and the difference between systemic forms such as patches and localized low-dose vaginal estrogen. They revisit the Women's Health Initiative data, where the estrogen-only arm showed a reduced breast cancer signal, and discuss the difference between bioidentical progesterone and older synthetic progestins.
Killen also describes the contraindications she takes seriously and the longevity tools she finds most and least convincing, from hyperbaric oxygen and red light to peptides and therapeutic plasma exchange. The most novel thread is immunological: estrogen appears to act as a coordinator of the female immune system, and its loss may explain the inflammation spike seen at perimenopause. The episode closes on the window of opportunity — the evidence that looks most protective for the brain comes from starting early rather than late.
Key quotes
5Because the ovaries are the pacemakers of aging in the human body.
You ovulate one egg, but 500 or 1,000 eggs are essentially lost along the way.
The women who took estrogen by itself had a 25-29% reduced breast cancer risk compared to women who are not using hormones.
You lose this, almost like the security director of the immune system.
It's the women who are not getting treatment that we know have increased cardiovascular disease and dementia risk.
Key ideas
9Women's longevity is a separate story
Killen treats female longevity as its own discipline rather than a footnote to male aging. The differences in how women age are large enough, she argues, to deserve their own research agenda and their own protocols.
Aging well means function, not just years
Her working definition of longevity is aging as well as you can for as long as you can. No tool reliably extends lifespan today, but plenty of tools support function, independence and the ability to keep doing what you want to do.
Stem cells work more like messengers
Clinically, cells are used less as replacement parts and more as signalling agents that tell your own cells to behave more youthfully, increase growth factors and blood flow, and calm inflammation. Numbers and activity both decline with age.
The ovaries as pacemakers of aging
When ovarian function falls, a cascade follows across the cardiovascular, metabolic, skeletal, muscular and neurological systems. Women who reach menopause later tend to live longer; those who reach it early and receive no hormonal support tend not to.
A feedback loop in the ovarian microenvironment
With age, inflammation, fibrosis and senescent cells accumulate in the ovaries. That hostile microenvironment accelerates egg loss, which in turn worsens the environment — a loop researchers are now trying to interrupt.
Estrogen, mitochondria and collagen
Even before cycles stop, falling estrogen is associated with mitochondria that work less efficiently across brain, blood vessels and muscle. Full-body collagen drops roughly 30% through the menopause transition, affecting skin, bone and joints alike.
Systemic versus localized forms
Killen separates estrogen into whole-body forms — patch, cream, pill, spray — and low-dose vaginal estrogen that largely stays in the pelvic floor. The distinction is mostly about dose, and it changes both the benefits and the side-effect picture.
The breast cancer story, revisited
In multiple studies, estrogen as hormone therapy has not shown increased breast cancer risk out to around ten years of use. The signal in the original trial came largely from a synthetic progestin, not from estrogen or bioidentical progesterone.
Estrogen as immune coordinator
The strong, vigilant female immune system appears to lose its master coordinator when estrogen falls, which may explain the inflammation rise seen at perimenopause. Killen is writing a book exploring this ovarian-immune link.
Practical takeaways
7- 1
Think about ovarian health early 18:00
Killen's first longevity question for women is how to keep ovaries healthy for as long as possible. That reframing moves the conversation years earlier than most people start it.
- 2
Lower the avoidable load 25:00
Higher phthalate exposure from personal care products and smoking are both associated with faster ovarian aging. Reviewing what goes on your skin and in your hair is a low-cost place to start.
- 3
Symptoms are not the only signal 30:00
Bone loss can accelerate in the two to three years before cycles stop, while a woman still feels fine. Feeling well is not the same as nothing changing underneath.
- 4
Know which form you are discussing 35:00
Local low-dose vaginal estrogen and a systemic patch are very different things with very different reach. Worth naming precisely in any conversation with a clinician trained in menopause care.
- 5
Basics before gadgets 52:00
Sleep, stress, movement, food, relationships and purpose come first; hyperbaric oxygen, red light and peptides are strategic additions, not substitutes. Killen notes red light has its strongest evidence in hair and skin.
- 6
A simple inflammation check 57:30
An hs-CRP reading, watched as a trend rather than a single number, can hint at rising inflammation during the perimenopause transition. Killen looks for values under one.
- 7
Timing appears to matter for the brain 1:00:30
The protective signal in the data comes from starting early in menopause, ideally within the first decade. Starting late is a different conversation with a different evidence base.
Topics & chapters
15Why women's longevity deserves its own field
Killen opens on the differences in how women age and why they are rarely discussed. The framing sets up the whole episode.
What aging well actually means
A working definition: as well as you can, for as long as you can. Function over raw lifespan.
What stem cells actually do
Cells as messengers rather than replacements, and why both number and activity drop with age. Sources include fat and bone marrow.
The ovaries as pacemakers of aging
Early menopause, premature ovarian insufficiency and the link to lifespan. Why ovarian function sets the tempo.
Egg loss and the hostile microenvironment
Hundreds of eggs lost per cycle, inflammation and fibrosis, and the research trying to slow it. Rapamycin and the ongoing trial.
Exposures that speed ovarian aging
Phthalates in personal care products, smoking, and metabolic conditions such as PCOS. Why the reproductive system is a whole-body indicator.
Estrogen 101
What estrogen is, the role of progesterone and testosterone, and what bioidentical means. Where the hormones come from.
Systemic versus local forms
Patch, pill, cream and spray versus low-dose vaginal estrogen. Pelvic floor health, recurrent infections and tissue quality.
Estrogen, skin and collagen
The face-cream trend, what small studies suggest about barrier function and hydration, and the roughly 30% collagen drop.
Testosterone and DHEA in women
Energy, mood and libido alongside real side effects such as acne and hair changes. Women make more testosterone than estrogen.
The breast cancer question
Revisiting the Women's Health Initiative, the role of synthetic progestin, and the BRCA data. What ten-year evidence does and does not cover.
Contraindications and educating doctors
Severe liver disease, unexplained bleeding, active hormone-sensitive cancer. Killen's mother's hip fracture and the education gap it revealed.
Longevity tools worth the time
Hyperbaric oxygen, red light therapy, peptides and therapeutic plasma exchange, weighed against the evidence and the hours they cost.
Ovarian aging and the immune system
Estrogen as coordinator of a vigilant immune system, the inflammation spike at perimenopause, and hs-CRP as a simple marker.
The window of opportunity
A listener question about starting at 62, and what the data says about early versus late starts for brain health.